Background
granulomas, Pulmonary sarcoidosis
LUNG INFLAMMATION, GRANULOMAS, PULMONARY SARCOIDOSIS
Pulmonary sarcoidosis is characterized by the accumulation of immune cells that form granulomas affecting the lungs. Efzofitimod (ATYR1923), a novel immunomodulator, selectively binds neuropilin 2, which is upregulated on immune cells in response to lung inflammation.